Delivery Order SPE2DR25D3501-SPE2DR26FL9BY
Award Date 11/20/25
Potential Completion Date 11/21/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,981.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on October 29, 2025. This non-competitive delivery order, classified as firm fixed price, is set to be completed by October 30, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,219.89 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 25, 2025. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $217,423.50 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 28, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of July 29, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,814.60 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order is non-competitive and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is delivering the product to its corporate office location in...
- The Defense Logistics Agency awarded a $14,249.13 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen units on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Dupixent (dupilumab) is a biologic...
- The Defense Logistics Agency awarded a delivery order valued at $21,536.39 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract employs firm fixed price pricing and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency awarded a $17,795.77 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on November 13, 2025, with completion expected by November 14, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory and allergic conditions,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,527.70 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $31,497.66 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dupixent 300 mg/2 mL pens. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by June 3, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various allergic and inflammatory conditions, including atopic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,336.93 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens (2 mL). The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery...